Florian Rader

Mar 18, 2024 | healio.com | Florian Rader |Richard Smith

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Dysregulated aldosterone production, sometimes driven by obesity, can cause hypertension. Targeted therapies that directly reduce aldosterone synthesis may help treat challenging cases of hypertension.

Jun 26, 2023 | citoday.com | Wayne Batchelor |Gizem Bilgili |Florian Rader |Brian O’Neill

PE Response Teams: Evolution Within the Revolution Early adopters of the PERT concept share practical insights on forming an effective team. Moderator: Rachel P.

Jun 22, 2023 | citoday.com | Gizem Bilgili |Florian Rader

Hypertension is the leading modifiable risk factor for the development of myocardial infarction, stroke, peripheral vascular disease, arrhythmias, and chronic kidney disease, causing morbidity and mortality among 30% of the population worldwide.1,2 Despite the broad availability of several effective antihypertensive drug classes that counter different blood pressure (BP)–raising mechanisms, most treated patients continue to have suboptimal BP control.3,4 At least 10% to 15% of hypertensive...

Jun 14, 2023 | dovepress.com | Florian Rader

Back to Journals » Integrated Blood Pressure Control » Volume 16 Authors Reyes KR, Rader F Received 14 June 2023 Accepted for publication 1 September 2023 Published 7 September 2023 Volume 2023:16 Pages 59—70 DOI https://doi.org/10.2147/IBPC.S392410 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Konstantinos Tziomalos Klevin Roger L Reyes, Florian Rader Smidt Heart Institute, Cedars-Sinai Medical Center, Los...